apollo

Select Address

Search Medicines
  • Login
  1. Home
  2. Adalipca 40 mg/0.8 ml Injection
  3. Adalipca 40 mg/0.8 ml Injection Substitute

Adalipca 40 mg/0.8 ml Injection Substitute

Substitutes safety advice
call Doctor

Verified Ingredients and Effects

Composition:

ADALIMUMAB-40MG

Uses:

Adalipca 40 mg/0.8 ml Injection is used in the treatment of autoimmune inflammatory diseases. The detailed uses of Adalipca 40 mg/0.8 ml Injection are as follows:<br/>• Treatment of Rheumatoid arthritis (RA): Adalipca 40 mg/0.8 ml Injection reduces inflammation, joint pain, and stiffness in adults with moderate to severe RA, improving mobility and quality of life.<br/>• Treatment of Juvenile idiopathic arthritis (JIA): Adalipca 40 mg/0.8 ml Injection is used in children to control inflammation, relieve joint symptoms, and support normal growth and development.<br/>• Treatment of Crohn’s disease: Adalipca 40 mg/0.8 ml Injection treats moderate to severe Crohn’s disease in adults and children by reducing intestinal inflammation when other treatments fail.<br/>• Treatment of Ulcerative colitis: Adalipca 40 mg/0.8 ml Injection is indicated for adults and children with moderate to severe ulcerative colitis who are unresponsive to conventional therapy.<br/>• Treatment of Ankylosing spondylitis: Adalipca 40 mg/0.8 ml Injection helps manage chronic back pain and stiffness by reducing spinal inflammation in adults.<br/>• Treatment of Psoriatic arthritis: Adalipca 40 mg/0.8 ml Injection improves joint and skin symptoms in adults by decreasing swelling, pain, and the formation of psoriatic skin lesions.<br/>• Treatment of Hidradenitis suppurativa: Adalipca 40 mg/0.8 ml Injection is used in adults and adolescents to reduce painful lumps and inflammation in areas like the armpits and groin.<br/>• Treatment of Uveitis: Adalipca 40 mg/0.8 ml Injection treats non-infectious uveitis in adults and children by lowering eye inflammation and helping preserve vision.<br/>• Treatment of Chronic plaque psoriasis: Adalipca 40 mg/0.8 ml Injection is used in adults with moderate to severe plaque psoriasis to reduce red, scaly patches and improve skin appearance.<br/>

Medicinal Benefits:

Adalipca 40 mg/0.8 ml Injection consists of Adalimumab, which belongs to the class of monoclonal TNF (Tumor necrosis factor) inhibitors. It works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive. This helps reduce inflammation and pain, redness, and inflammation (swelling) caused by various autoimmune diseases.

FAQs

Adalipca 40 mg/0.8 ml Injection is used to treat Rheumatoid arthritis, Ankylosing spondylitis, Psoriatic arthritis, Plaque psoriasis, Crohn’s disease, Uveitis and Ulcerative colitis.

Adalipca 40 mg/0.8 ml Injection contains Adalimumab, which works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive.

Adalipca 40 mg/0.8 ml Injection affects your immune system and makes you more susceptible to infections. Hence, it is not recommended in people with active infections like tuberculosis or abnormal liver enzymes. Adalipca 40 mg/0.8 ml Injection can also increase the risk of developing cancers; hence, informing your doctor if you have a history of any cancer is essential.

Adalipca 40 mg/0.8 ml Injection is an antirheumatic medicine that belongs to the TNF (tumor necrosis factor) inhibitor class. It contains the active ingredient Adalimumab.

Treatment with Adalipca 40 mg/0.8 ml Injection can help reduce inflammation, pain, redness, and swelling associated with various autoimmune disorders.

Adalipca 40 mg/0.8 ml Injection which contains Adalimumab, can weaken your immune system. Since it affects the immune system, it may increase your risk of developing infections. It is important to follow your doctor's advice and inform them if you have any existing infections or health concerns before starting treatment.

Adalipca 40 mg/0.8 ml Injection can be used alongside other arthritis medicines such as methotrexate, prednisolone, naproxen, ibuprofen, and paracetamol. However, Adalipca 40 mg/0.8 ml Injection should not be used with other biological disease-modifying antirheumatic drugs (bDMARDs).

Adalipca 40 mg/0.8 ml Injection should be stopped before surgery. It can be resumed after the operation, once the wound has healed and there is no infection, as determined by your surgeon and rheumatologist.

Adalipca 40 mg/0.8 ml Injection causes side effects such as rash, headache, sinusitis, upper respiratory infections, fever, and application site reactions. Therefore, please contact a doctor if these do not reduce and persist for longer durations.